Skip to content

BioSig Technologies, Inc. STEX Debt Instrument Convertible Conversion Price

Debt Instrument Convertible Conversion Price at other companies

XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$1,000.00
NextNRG, Inc. Common Stock logo
NextNRG, Inc. Common StockNXXT
$0.00
Envoy Medical logo
Envoy MedicalCOCH
$11.500.0%
Kopin logo
KopinKOPN
$4.40
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
$6.02
KEE
Keel Infrastructure Corp. Common StockKEEL
$5.280.0%

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentConvertibleConversionPrice1.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s debt instrument convertible conversion price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s debt instrument convertible conversion price?
BioSig Technologies, Inc. (STEX) reported debt instrument convertible conversion price of $6.02 in Q1 2026.
What does debt instrument convertible conversion price mean?
The predetermined price at which convertible debt holders can exchange their debt for equity shares. This metric is essential for assessing the potential for future equity dilution and the company's cost of financing.